Inactief instrument

Koers Diamedica Therapeutics INC Nasdaq

Aandelen

Duur

Periode

Stijl

DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange	09-01-19
UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease	03-01-19

Sector